J Herms
Overview
Explore the profile of J Herms including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1339
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaiser L, Quach S, Zounek A, Wiestler B, Zatcepin A, Holzgreve A, et al.
Eur J Nucl Med Mol Imaging
. 2024 Feb;
51(8):2371-2381.
PMID: 38396261
Purpose: According to the World Health Organization classification for tumors of the central nervous system, mutation status of the isocitrate dehydrogenase (IDH) genes has become a major diagnostic discriminator for...
2.
Biczok A, Thorsteinsdottir J, Karschnia P, Ruf V, Tonn J, Herms J, et al.
Acta Neuropathol Commun
. 2023 Jan;
11(1):12.
PMID: 36641486
Extracranial metastases of intracranial meningiomas are rare. Little is known about the mutational pattern of these tumors and their metastatic seeding. Here, we retrospectively explored the molecular alterations of these...
3.
Bodensohn R, Forbrig R, Quach S, Reis J, Boulesteix A, Mansmann U, et al.
ESMO Open
. 2022 Mar;
7(2):100424.
PMID: 35248822
Background: Pseudoprogression (PsP) or radiation necrosis (RN) may frequently occur after cranial radiotherapy and show a similar imaging pattern compared with progressive disease (PD). We aimed to evaluate the diagnostic...
4.
Korzhova V, Marinkovic P, Njavro J, Goltstein P, Sun F, Tahirovic S, et al.
Commun Biol
. 2021 Dec;
4(1):1368.
PMID: 34876653
Alzheimer's disease (AD) is associated with aberrant neuronal activity, which is believed to critically determine disease symptoms. How these activity alterations emerge, how stable they are over time, and whether...
5.
Unterrainer M, Fleischmann D, Vettermann F, Ruf V, Kaiser L, Nelwan D, et al.
Eur J Nucl Med Mol Imaging
. 2019 Sep;
47(6):1368-1380.
PMID: 31486876
Background: The 18-kDa translocator protein (TSPO) is overexpressed in brain tumours and represents an interesting target for glioma imaging. F-GE-180, a novel TSPO ligand, has shown improved binding affinity and...
6.
Unterrainer M, Fleischmann D, Diekmann C, Vomacka L, Lindner S, Vettermann F, et al.
Eur J Nucl Med Mol Imaging
. 2018 Sep;
46(3):580-590.
PMID: 30244386
Background: PET represents a valuable tool for glioma imaging. In addition to amino acid tracers such as F-FET, PET targeting the 18-kDa mitochondrial translocator-protein (TSPO) is of high interest for...
7.
Unterrainer M, Winkelmann I, Suchorska B, Giese A, Wenter V, Kreth F, et al.
Eur J Nucl Med Mol Imaging
. 2018 Mar;
45(6):1078.
PMID: 29541813
The name of M. Unterrainer was inadvertently presented as M. Unterrrainer in the original article.
8.
Unterrainer M, Winkelmann I, Suchorska B, Giese A, Wenter V, Kreth F, et al.
Eur J Nucl Med Mol Imaging
. 2018 Mar;
45(7):1242-1249.
PMID: 29487977
Purpose: For the clinical evaluation of O-(2-F-fluoroethyl)-L-tyrosine (F-FET) PET images, the use of standard summation images obtained 20-40 min after injection is recommended. However, early summation images obtained 5-15 min...
9.
Brendel M, Jaworska A, Herms J, Trambauer J, Rotzer C, Gildehaus F, et al.
Mol Psychiatry
. 2015 Sep;
20(10):1141.
PMID: 26401838
No abstract available.
10.
Brendel M, Jaworska A, Herms J, Trambauer J, Rotzer C, Gildehaus F, et al.
Mol Psychiatry
. 2015 Jun;
20(10):1179-87.
PMID: 26055427
In a positron-emission tomography (PET) study with the β-amyloid (Aβ) tracer [(18)F]-florbetaben, we previously showed that Aβ deposition in transgenic mice expressing Swedish mutant APP (APP-Swe) mice can be tracked...